Biomarker combinations in predicting sepsis in hospitalized children with fever

Linda Rautiainen1, Anna Cirko2,3, Jana Pavare2,3

  • 1Department of Pediatrics, Riga Stradins University, Riga, LV1007, Latvia. linda.e.rautiainen@gmail.com.

BMC Pediatrics
|May 13, 2022
PubMed

Insights

Biomarkers like C-reactive protein (CRP) and cytokines show promise in identifying sepsis, a critical illness. Combining CRP with other markers, such as soluble Fas (sFAS), improves sepsis prediction accuracy.

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Biochemistry

Background:

  • Sepsis is a major global cause of critical illness, characterized by a dysregulated inflammatory response to infection.
  • Accurate methods for early sepsis recognition and mortality prediction are crucial for patient outcomes.
  • Identifying reliable biomarkers for inflammatory responses in sepsis is an ongoing challenge.

Purpose of the Study:

  • To investigate and compare the predictive validity of various biomarkers for sepsis in patients presenting with fever.
  • To evaluate both pro-inflammatory and anti-inflammatory markers for their diagnostic performance in sepsis.
  • To explore the potential of biomarker combinations to enhance sepsis prediction.

Main Methods:

  • 165 febrile patients were enrolled; 55 met sepsis criteria (pSOFA).
  • Blood samples were collected at inclusion and 24 hours.
  • Levels of C-reactive protein (CRP), procalcitonin (PCT), IL-6, IL-8, sFAS, and sVCAM-1 were measured.

Main Results:

  • CRP, PCT, IL-6, IL-8, and sFAS levels were significantly elevated in sepsis patients.
  • CRP demonstrated the highest area under the curve (AUC) of 0.799 for sepsis prediction among single markers.
  • Combining CRP with sFAS improved sensitivity, and a panel including CRP, IL-6, sFAS, and sVCAM-1 achieved the highest AUC (0.830).

Conclusions:

  • While CRP shows good predictive value for sepsis, combining it with other biomarkers like IL-6, sFAS, and sVCAM-1 significantly enhances diagnostic performance.
  • Single cytokine markers did not exhibit significant diagnostic utility.
  • Biomarker panels offer a more robust approach to identifying sepsis in febrile patients.